Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
JPMorgan Chase reported net income of $15.3 billion for the third quarter of 2026, with a return on tangible common equity of 20%. Total assets grew to over $5.09 trillion, while the firm maintained a strong CET1 capital ratio of 14.0%. Results for the first nine months of 2026 were bolstered by a $4.6 billion net gain related to Visa shares recorded in the second quarter.
Transocean Ltd. reported a net income of $26 million for the third quarter of 2026, a significant recovery from a $1.92 billion loss in the prior year period which was impacted by heavy asset impairments. For the nine months ended September 30, 2026, the company generated $574 million in operating cash flow and reduced its long-term debt to $4.56 billion.
Healthpeak Properties reported total revenues of $820.9 million for the third quarter of 2026, up from $705.9 million in the prior year, driven by a significant increase in resident fees and services. Net income attributable to the company was $17.3 million ($0.02 per share), a recovery from a net loss of $117.1 million in the same period of 2025.
Community Healthcare Trust reported Q3 2026 net income of $3.1 million and total revenue growth of 4% sequentially, reflecting progress on its strategic plan. The company declared a quarterly dividend of $0.33 per share and noted it has $99.0 million in properties under definitive purchase agreements expected to close between late 2026 and early 2028.
Columbus McKinnon reported total assets of $4.68 billion as of September 30, 2026, with a significant portion of its capital structure consisting of $2.26 billion in long-term debt and $818.4 million in preferred stock. The company is currently integrating the Kito Crosby Acquisition and managing a transition following the divestiture of its legacy U.S. power chain hoist operations.
Comscore reported third quarter 2026 revenue of $76.2 million, a 14.3% decrease year-over-year, and a net loss of $65.5 million primarily driven by a $57.3 million non-cash goodwill impairment charge. The company is executing a transformational ROI strategy to realign its cost structure and reaffirmed its full-year 2026 revenue guidance.
Term
Q3 2026
“During the third quarter, we announced our transformational ROI strategy, which was designed to realign our business and cost structure, optimize our operations, and invest in higher-potential growth areas. Our team executed against this new operating model with a strong sense of urgency, allowing us to achieve significant cost savings in the quarter.”
Matt McLaughlin, Chief Executive Officer of Comscore
“We are taking aggressive actions to rationalize our operational footprint and are focused on serving customers in our core business, as well as identifying and capitalizing on long-term growth opportunities in the evolving media landscape. I'm proud of the difficult work our team has done to execute against our plan and remain confident that we will exit the year well positioned to transform the business in 2027 and begin investing for long-term growth.”
Matt McLaughlin, Chief Executive Officer of Comscore
Redwood Trust reported third-quarter 2026 financial results, highlighted by a 26% annualized return on capital in its mortgage banking platforms and a strategic plan to transition to a C-corporation in 2027. The company reported a GAAP net loss of $0.39 per share, primarily driven by fair value changes in its legacy investment segment as it accelerates the resolution of those assets.
PACS Group, Inc. reported total assets of $5.9 billion as of September 30, 2026, with 158,723,533 shares of common stock outstanding. The company is classified as an accelerated filer and an emerging growth company, operating primarily in the healthcare facility sector with significant geographic concentration in California.
For the quarter ended September 30, 2026, Block, Inc. reported total net revenue of $6.72 billion and net income attributable to common stockholders of $565.6 million. Gross profit grew to $3.24 billion, though operating expenses increased significantly to $2.81 billion, driven by higher general and administrative costs and credit losses.
BOK Financial Corp reported a total loan portfolio of $27.7 billion as of September 30, 2026, driven by growth in energy, commercial real estate, and mortgage finance loans. The company also realized $33.5 million in gains from the sale of Visa Class C shares and continues to hold Visa B-3 shares at a zero cost basis due to transfer restrictions.
Celanese Corp reported net sales of $2,556 million for the third quarter of 2026, a slight increase from $2,419 million in the prior year period. The company returned to profitability with net earnings of $78 million compared to a net loss of $1,353 million in Q3 2025, which had been impacted by significant other charges.
AMD reported record third-quarter 2026 revenue of $13.4 billion, a 45% increase year-over-year, driven by a 97% surge in Data Center segment revenue. The company achieved GAAP net income of $2.4 billion and diluted EPS of $1.46, benefiting from strong demand for Instinct GPUs and EPYC CPUs.
Term
Q3 2026
“We delivered a record quarter with revenue exceeding the high end of our guidance as Data Center segment sales nearly doubled year-over-year. Demand for our Instinct and EPYC products continued to strengthen, and we expect growth to accelerate further in the fourth quarter as we scale Helios and ‘Venice’ production.”
Dr. Lisa Su, AMD chair and CEO
“Third quarter revenue grew 45% year-over-year to a record $13.4 billion, while non-GAAP earnings per share grew 74%, demonstrating the significant operating leverage in our business model as our Data Center business drives scale.”
Jean Hu, AMD executive vice president, chief financial officer and treasurer
Aquestive Therapeutics reported Q3 2026 financial results and provided a regulatory update for its lead candidate Anaphylm, which has a PDUFA goal date of March 16, 2027. The company is preparing for a potential U.S. launch and plans to submit regulatory filings in Canada and the EU in late 2026 and early 2027.
Term
Q3 2026
“With a PDUFA goal date of March 16, 2027, we believe we have a clear path to making Anaphylm available to patients and caregivers, if approved. For decades, people at risk of anaphylaxis have had limited treatment options. We believe Anaphylm - designed to be easy to carry and use confidently whenever and wherever it may be needed - has the potential to address important unmet needs.”
Daniel Barber, President and Chief Executive Officer of Aquestive
Generac reported a specific warranty provision of $14.3 million in Q3 2026 for clean energy products and a $206.5 million legal settlement payment. The company also noted losses from four immaterial business dispositions in 2026 and recorded contingent consideration increases related to the Enercon acquisition.
PACS Group reported third quarter 2026 revenue of $1.50 billion, an 11.5% increase year-over-year, driven by same-store occupancy improvements to 91.3%. The company deployed $213 million for M&A during the quarter and highlighted that nearly 79% of its skilled nursing portfolio achieved 4 or 5 star CMS Quality Measure ratings.
Term
Q3 2026
“Our third quarter results reflect the continued progress our teams are making across the organization, both in the quality of care we provide and the performance of our facilities. Same-store revenue increased 6.4%, occupancy improved to 91.3%, and skilled mix continued to strengthen.”
Jason Murray, PACS Chief Executive Officer
“Our third quarter results demonstrate the increasing earnings power of the PACS operating model, with Adjusted EBITDA growth significantly outpacing revenue growth. Revenue increased 11.5% year-over-year to $1.50 billion, while Adjusted EBITDA grew 33.6% to $175.7 million.”
Champion Homes reported second quarter fiscal 2027 financial results with net sales increasing 6.2% to $727.0 million. The company also announced that its Board of Directors approved a $50.0 million increase to its existing share repurchase program, bringing the total authorization to $150.0 million.
“We delivered strong results in our second quarter that were in line with our expectations. Our team’s focused execution against our strategic priorities enabled us to outperform the housing market in the quarter and build meaningful order momentum.”
Omega Healthcare Investors reported Q3 2026 net income of $87 million and Adjusted FFO of $0.82 per share. The company raised its full-year 2026 AFFO guidance midpoint to $3.29 per share following $1.5 billion in year-to-date investment activity, including a significant post-quarter transition of 32 Florida facilities to PACS Group.
Term
Q3 2026
“We are pleased to report strong third quarter results, as we continued to grow FAD per share year over year, while reducing leverage to the lowest level in the Company’s history. As a result, we were again able to increase our AFFO guidance, moving the midpoint up by five cents to $3.29.”
Matthew Gourmand, Omega’s Chief Executive Officer
“The investments made in the third and early fourth quarter highlight the breadth of opportunities available to us to continue to grow shareholder value. The pipeline remains strong, and we expect to make further accretive investments through the remainder of this year and into early 2027.”
First United Corporation reported net income of $19.5 million for the first nine months of 2026, compared to $18.7 million in 2025. The increase was driven by higher net interest income of $56.3 million, though partially offset by a rise in total credit loss expenses to $3.6 million and increased operating expenses.
Revolve Group reported third quarter 2026 financial results with net sales of $356.0 million, a 20% increase year-over-year driven by 18% growth in active customers. While top-line momentum was strong, net income decreased 27% to $15.5 million, impacted by higher marketing investments and shipping rates.
Term
Q3 2026
“We delivered a strong third quarter, highlighted by net sales growth of 20% or more across our segments, REVOLVE and FWRD, and in domestic and international markets. Supporting our top-line momentum was 18% growth in active customers year-over-year, our fourth consecutive quarter of growth acceleration.”
Mike Karanikolas, co-founder and co-CEO
“Our strong top line growth and customer engagement metrics are a reflection of our brand strength and a result of our investments in brand building, physical retail expansion and key partnerships, including the recent launch of REVOLVE Los Angeles and our inaugural REVOLVE Magazine, our new joint venture with Donatella Versace, and recently-announced expanded partnerships with Kendall Jenner and Dwyane Wade.”
Latham Group reported Q3 2026 net sales of $182.2 million, up 12.5% year-over-year, driven by strong demand for fiberglass pools and growth in 'Sand States' like Florida and Texas. The company's board also approved a new $100 million share buyback program and narrowed its full-year 2026 guidance.
Term
Q3 2026
“We delivered strong third quarter and year-to-date results, demonstrating continued success in material conversion, reinforcing our expectation of further market share expansion, and achieving considerable operating leverage while investing to accelerate growth.”
RxSight, Inc. reported 41,929,222 shares of common stock outstanding as of October 29, 2026. The company anticipates revenue growth through expanded sales territories and increased doctor adoption of its Light Adjustable Lens (LAL) system, while maintaining that current capital is sufficient to fund operations for at least 12 months.
Seadrill reported third quarter 2026 results with total operating revenues of $428 million and an adjusted EBITDA of $121 million. The company secured $800 million in new contract awards and extensions subsequent to its August fleet status report and increased its full-year 2026 revenue and EBITDA guidance.
Term
Q3 2026
“Seadrill generated $179 million of Free Cash Flow in the third quarter, delivering on our commitment to convert backlog into cash. Over 85% of available drillship days are now contracted in 2027, further enhancing visibility into next year’s earnings and cash flow.”
For the quarter ended September 30, 2026, American Well reported revenue of $49.0 million, a decrease from $56.3 million in the prior year period. The company significantly narrowed its net loss to $11.0 million compared to $31.9 million in 2025, driven by substantial reductions in research and development and general and administrative expenses.
EVERTEC reported Q3 2026 revenue of $283.0 million, a 24% increase year-over-year, driven by acquisitions and organic growth in Latin America. The company raised its full-year 2026 outlook for both revenue and adjusted earnings per share while completing the acquisition of blockchain infrastructure firm BBChain.
Term
Q3 2026
“Evertec’s transformation is translating into strong results. We have built a broader, more diversified company with greater scale, deeper capabilities and more opportunities to grow across Puerto Rico and Latin America.”
Capital One Financial Corp reported 601,533,153 shares of common stock outstanding as of September 30, 2026. The company continues to integrate Discover Financial Services following their May 2025 merger, which expanded its operations to include personal loans and the Global Payment Network.
FormFactor, Inc. reported significant growth for the third quarter of 2026, with revenues increasing to $280.5 million compared to $202.7 million in the prior year period. Net income rose substantially to $73.8 million, driven by higher gross profits and improved operating margins despite increased factory start-up costs.
UL Solutions Inc. reported a significant increase in net income for the nine months ended September 30, 2026, reaching $469 million compared to $274 million in the prior year, largely driven by a $191 million gain on divestiture. Revenue grew 5.9% year-over-year to $2.4 billion, and the company reorganized its reporting segments into Industrial, Risk & Compliance Software, and Consumer segments.
Contineum Therapeutics reported cash and cash equivalents of $75.2 million as of September 30, 2026, compared to $75.6 million at the end of 2025. The company remains in the early stages of clinical development, heavily dependent on its lead candidate PIPE-791 and its collaboration with J&J for PIPE-307.
Huron Consulting Group reported a 12.8% increase in total revenues to $1.42 billion for the nine months ended September 30, 2026, compared to the prior year. Net income rose to $82.9 million from $74.4 million, driven by strong performance in operating income despite higher interest expenses and a significant increase in long-term debt to $793.9 million.
American Well Corp (Amwell) reported Q3 2026 total revenue of $49.0 million, exceeding its previous guidance, and a net loss of $11.0 million. The company raised its full-year 2026 revenue outlook to a range of $204-$206 million and reiterated its goal to achieve positive cash flow from operations in the fourth quarter of 2026.
Term
Q3 2026
“Health plans and employers want engagement, outcomes and proof, and Amwell’s single platform is built to deliver all three. Across six focus areas that all run on one platform, we are activating more members, simplifying their experience and deepening their relationship with clinicians, giving customers choice without the sprawl, demonstrating outcomes, and using a common data structure to show what works. We expect to generate positive cash flow from operations in the fourth quarter, and we believe we are well positioned to be the trusted platform where AI-powered care runs.”